Related Experiment Videos

Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of

P Chamnan1, R K Simmons, R Jackson

  • 1MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Diabetologia
|September 23, 2010
PubMed

Insights

Non-diabetic high blood sugar (hyperglycaemia) significantly increases cardiovascular disease (CVD) risk, especially with other risk factors. An integrated CVD risk assessment is crucial for effective management.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Non-diabetic hyperglycaemia is often overlooked or treated as a simple risk category in cardiovascular disease (CVD) assessment.
  • Current approaches frequently isolate hyperglycaemia from other contributing vascular risk factors.

Purpose of the Study:

  • To evaluate hyperglycaemia as a continuous risk factor for CVD.
  • To determine the absolute CVD risk in individuals with varying HbA1c levels and concurrent risk factors.
  • To highlight the importance of considering hyperglycaemia within a multifactorial risk context.

Main Methods:

  • Utilized data from 10,144 participants in the European Prospective Investigation of Cancer-Norfolk cohort.
  • Calculated cardiovascular disease (CVD) rates across different HbA1c levels.
  • Stratified analyses by the presence and severity of traditional CVD risk factors.

Main Results:

  • Significant variations in CVD rates were observed across HbA1c levels, influenced by other risk factors.
  • Non-diabetic individuals with HbA1c <5.5% showed markedly increased CVD rates when traditional risk factors were present.
  • Absolute CVD risk in non-diabetic individuals with HbA1c <5.5% and multiple risk factors exceeded that of individuals with higher HbA1c but fewer risk factors.

Conclusions:

  • Cardiovascular risk in non-diabetic hyperglycaemia is substantially modified by the presence of other CVD risk factors.
  • An integrated assessment of cardiovascular risk, considering the combination of all factors, is recommended over isolated diagnoses.
  • Focus should shift towards a holistic evaluation of an individual's combined risk profile for better treatment strategies.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...